Vistin Pharma
Be the first to follow this company
Vistin Pharma is a Norwegian pharmaceutical company. The company conducts research and development as well as further production of pharmaceutical substances (API), mainly the substances metformin, codeine phosphate, and Pholcodine. The substances are mainly used in the treatment of diabetes. The company operates worldwide, with the largest presence in the Nordic market. Vistin Pharma was founded in 2015 and is headquartered in Oslo, Norway.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Oslo Børs
VISTN
Daily low / high price
-
Market cap
-
Turnover
-
Volume
-
Financial calendar
General meeting
23.05.2024
Half year dividend
05.06.2024
Interim report
23.08.2024
Interim report
31.10.2024
Half year dividend
06.11.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Intertrade Shipping AS | 28.4 % | 28.4 % |
Holmen Specialfond | 8.5 % | 8.5 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Vistin Pharma ASA: Annual Report 2023
Vistin Pharma ASA: First quarter 2024 financial results
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools